Pharmatica

In this special Scientific Council Spotlight episode of The Discovery Loop podcast, host Shubhangi Dua, Journalist, Podcast Producer and Podcast Host at Pharmatica.io, sits down with Deepankar Nayak, the CEO of Deep Longevity. Nayak also serves on Pharmatica’s Scientific Council.

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

“The pharma industry is beginning to look at biological age as a surrogate endpoint to improve clinical trials."

In the recent episode of The Clinical Compass podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, is joined by Dr Amber Hill, Founder and CEO of Research Grid. They talk about how pharmaceutical companies and their leaders should approach the use of AI in clinical trials.

In the recent episode of The Discovery Loop podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io, sat down with Diana Andrade, Founder & Managing Director at RD Privacy and Data Protection Officer (DPO) for Biopharma and Life Sciences. They talk about the current state of data protection regulations and how enterprises can innovate responsibly.

In the recent episode of The Chain Reaction podcast, Nour AlSaleh, Founder and CEO of Veragence Pharma Consultancy, sat down with host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io and EM360Tech. AlSaleh shares her expertise on maintaining data integrity in this new era of AI and changing policies.

Kate O’Reilly, President & Chair of the Healthcare Businesswomen’s Association (HBA) Dublin-Ireland Chapter & Healthcare Transformation Partner at Roche, discusses AI in pharma, patient engagement, and the future of healthcare innovation.

In the recent episode of the Digital Pulse podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, sat down with Lara Masad, an AI and Data Innovation independent consultant, to clarify the key distinctions in AI and machine learning models. Furthermore, Masad explains how pharmaceutical companies benefit from using AI models.

Trisha Pillay speaks with Judit Mora, CEO of Nuumad, on Digital Pulse discussing pharmacy innovation, market access barriers, and new models for faster patient access to healthcare.

Trisha Pillay speaks with Dineshree Naiker, co-founder of Umsebe Healthcare, on Chain Reaction discussing regulatory leadership, pharmaceutical supply chains, and improving patient access to medicines.

Exclusive Pharmatica Content

Explore expert-led podcasts, pharmaceutical intelligence, life sciences insights and research-driven analysis from leading industry voices. Pharmatica delivers trusted biotech news, drug development trends and commercial intelligence for professionals across the pharmaceutical sector.

Nicole Dale

Better Predictive Modelling for Better Drug Development

Pharmatica image showing AI-powered pharmaceutical drug discovery environment showing predictive modelling, molecular research, and connected scientific data.

Discover how predictive modelling, QSP, AI, and systems biology creates better drug development by connecting biological evidence with better predictions.

Nicole Dale

FDA Oncology Trial Guidance Targets Eligibility Barriers

Pharmatica image showing new FDA oncology clinical trial guidance for clinical trial eligibility represented through connected patient assessment, clinical research data, and trial pathways.

FDA oncology clinical trial guidance targets restrictive eligibility criteria, covering performance status, washout periods, medications, and laboratory values.

Nicole Dale

EHR Patient Recruitment Gets A Reality Check

Pharmatica image representing EHR patient recruitment technology connecting electronic health records, clinical trial eligibility data, and patient-trial matching.

EHR patient recruitment could improve clinical trial matching, but workflow integration, data quality, interoperability, and AI validation remain key challenges.

Nicole Dale

Could q-CAR Redefine Drug Discovery?

Pharmatica image for q-CAR drug discovery showing dynamic protein conformations, ligand binding, and AI-driven molecular analysis.

Find out how q-CAR drug discovery moves beyond static protein structures by linking protein dynamics, ligand activity, and AI to precision drug design.

Nicole Dale

FDA Generic Peptides Guidance Sets New Expectations

Pharmatica visual of the FDA generic peptides guidance showing peptide molecular structure and regulatory assessment of generic peptide medicines.

Revised FDA draft guidance for generic peptide products updates expectations for ANDAs, impurities, structure, immune response, and biological activity.

Nicole Dale

The Ethics of Decentralised Clinical Trials

Pharmatica image representing decentralised clinical trials using remote monitoring, digital health technology, and telehealth to connect clinical research participants with investigators.

Ethical obligations in decentralised clinical trials extend beyond consent and privacy. Sponsors must protect safety, scientific validity, equity, and oversight.

Nicole Dale

Nanocarriers Target the Eye for Better Ocular Drug Delivery

Pharmatica image representing ocular drug delivery using nanocarriers to improve therapeutic targeting of the eye and retinal tissues.

Ocular drug delivery faces major biological barriers. Nanocarriers could improve bioavailability, tissue targeting, controlled release, and treatment for difficult eye diseases.

Nicole Dale

Making Flexibility Work with Adaptive Clinical Trials

Pharmatica image showing two clinical researchers in white laboratory coats reviewing trial data on a digital tablet in a modern pharmaceutical research environment. The background shows laboratory equipment and translucent scientific graphics, symbolising adaptive clinical trial design, evidence‑driven decision‑making, and digital data integration in clinical development.

Adaptive clinical trials can improve efficiency, reduce patient burden, and support faster development through structured, evidence-based flexibility.

Nicole Dale

Collaborating for R&D Success in Drug Discovery

Pharmatica realistic representation of collaboration in drug discovery showing interlocking green and blue puzzle pieces with a DNA helix emerging from their center, capsules in front, a glowing molecular data screen behind, and a 3D molecular model to the right on a bright white background.

Collaboration in drug discovery can shape pharma R&D success. Explore the evidence on pharma partnerships, knowledge sharing, governance, and innovation.

Nicole Dale

AI in GMP Manufacturing: Are Regulators Ready for Digital Factories?

Pharmatica image representing AI in pharmaceutical GMP manufacturing using machine learning, predictive maintenance, digital quality management, continuous manufacturing, and smart pharmaceutical production.

Learn how AI in pharmaceutical GMP manufacturing is improving quality, data integrity, predictive maintenance, and regulatory compliance in modern drug production.

Nicole Dale

Growing Patient and Public Involvement in Clinical Trials

Pharmatica image representing public and patient involvement in clinical trials. Shows a diverse group of clinical trial participants and researchers engaged in collaborative discussion around a bright white table in a modern research environment. A female doctor in a white lab coat leads the conversation, surrounded by older and younger participants of different ethnic backgrounds. Digital screens in the background display molecular structures and clinical data in blue tones, symbolising transparency.

Patient and public involvement in clinical trials improves study design. Learn why better reporting is essential for transparent, patient-centred research.

Nicole Dale

Psychedelic Drug Discovery Gets a New Preclinical Framework

Pharmatica detailed rendering of a neuron firing electrical impulses through dendrites and axons in vivid green tones, symbolising neural connectivity and communication in psychedelic drug discovery, neuroplasticity, 5-HT2A receptor pharmacology, CNS drug development, psychoplastogens, and therapeutic neuroscience research.

Find out how psychedelic drug discovery is evolving through receptor pharmacology, behavioural science, and neuroplasticity to develop safer CNS therapeutics.

Content type

Topic

Articles, expert interviews, and insights from life sciences leaders

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

Better Predictive Modelling for Better Drug Development

FDA Oncology Trial Guidance Targets Eligibility Barriers

EHR Patient Recruitment Gets A Reality Check

Could q-CAR Redefine Drug Discovery?

FDA Generic Peptides Guidance Sets New Expectations

The Ethics of Decentralised Clinical Trials

Nanocarriers Target the Eye for Better Ocular Drug Delivery

Making Flexibility Work with Adaptive Clinical Trials

Collaborating for R&D Success in Drug Discovery

AI in GMP Manufacturing: Are Regulators Ready for Digital Factories?

Growing Patient and Public Involvement in Clinical Trials

Psychedelic Drug Discovery Gets a New Preclinical Framework